FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle

Jun Shen, Orestis Papasouliotis, Eileen T. Samy, Philipp Haselmayer, Peter Chang, Victor Ona, Amy KaoAnnals 2018 · DOI

BibTeX
@article{shen2018fri,
  author = {Jun Shen and Orestis Papasouliotis and Eileen T. Samy and Philipp Haselmayer and Peter Chang and Victor Ona and Amy Kao},
  title = {{FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle}},
  journal = {Annals},
  year = {2018},
  doi = {10.1136/annrheumdis-2018-eular.2050},
}

Loading related content...

Figure